Patents Assigned to Anteis SA
-
Patent number: 11331305Abstract: The invention provides compositions for stimulating the formation of one or more extracellular matrix components that contain a lipoaminoacid derivative of the tripeptide carnosine such as N-Octanoyl Carnosine. Also provided are compositions containing N-Octanoyl Carnosine in combination with selected tripeptide and/or tetrapeptides as well as pharmaceutical and/or cosmetic compositions containing such compositions. The invention further provides methods of using the compositions and compositions of the invention to treat, alleviate, and/or ameliorate a symptom, condition, disorder, or disease of the skin or mucosa, wherein the symptom, condition, disorder, or disease is associated with changes in extracellular matrix components.Type: GrantFiled: December 10, 2019Date of Patent: May 17, 2022Assignee: ANTEIS SAInventor: Frank Dreher
-
Patent number: 10543195Abstract: The invention provides compositions for stimulating the formation of one or more extracellular matrix components that contain a lipoaminoacid derivative of the tripeptide carnosine such as N-Octanoyl Carnosine. Also provided are compositions containing N-Octanoyl Carnosine in combination with selected tripeptide and/or tetrapeptides as well as pharmaceutical and/or cosmetic compositions containing such compositions. The invention further provides methods of using the compositions and compositions of the invention to treat, alleviate, and/or ameliorate a symptom, condition, disorder, or disease of the skin or mucosa, wherein the symptom, condition, disorder, or disease is associated with changes in extracellular matrix components.Type: GrantFiled: May 25, 2016Date of Patent: January 28, 2020Assignee: ANTEIS SAInventor: Frank Dreher
-
Patent number: 9713604Abstract: The invention provides non-irritating, stable topical compositions including at least Vitamin C, Vitamin E and a polyphenol antioxidant. Such compositions can be used to facilitate the prevention or treatment of free oxygen, nitrogen, and/or other free radical related skin damage. Also provided are methods for modifying free radical damage to skin by administering such compositions in an amount sufficient to treat and/or prevent free radical damage to the skin.Type: GrantFiled: April 22, 2014Date of Patent: July 25, 2017Assignee: ANTEIS SAInventor: Frank Dreher
-
Patent number: 9629856Abstract: The present invention provides compositions containing one or more antimicrobial peptide sequestering compounds and methods for topical application of such compositions to the skin to treat skin diseases and disorders such as rosacea in humans.Type: GrantFiled: March 2, 2011Date of Patent: April 25, 2017Assignee: Anteis SAInventor: Frank Dreher
-
Patent number: 9468779Abstract: The invention relates to a polysaccharide gel of natural origin for dermatological use that comprises an aqueous solution of the polysaccharide of 0.1 to 5% by weight/volume, for example hyaluronic acid, and a viscous and strongly hydrophilic biocompatible alcohol at 0.5-5% by weight/volume, for example glycerol, and optionally the adjuvants that are commonly used in dermatology. The gel is prepared by mixing the polysaccharide solution and the strongly hydrophilic viscous alcohol before sterilizing the entire mixture by, for example, moist heat.Type: GrantFiled: February 14, 2014Date of Patent: October 18, 2016Assignee: ANTEIS SAInventor: Gilles Bos
-
Publication number: 20140194850Abstract: An accessory for a syringe is disclosed, including a body with a proximal end having at least one zone for application of an injection force in order to apply a force for discharging a product from the syringe, and a distal end having a bearing element for bearing against a needle mounted on the mouth of the syringe with a force that includes a radial component perpendicular to the longitudinal axis of the syringe and directed towards the centre of the syringe. An assembly including such an accessory and a syringe is also disclosed.Type: ApplicationFiled: July 2, 2012Publication date: July 10, 2014Applicant: ANTEIS SAInventor: Cyrille Vinchon
-
Publication number: 20140162975Abstract: The invention relates to a polysaccharide gel of natural origin for dermatological use that comprises an aqueous solution of the polysaccharide of 0.1 to 5% by weight/volume, for example hyaluronic acid, and a viscous and strongly hydrophilic biocompatible alcohol at 0.5-5% by weight/volume, for example glycerol, and optionally the adjuvants that are commonly used in dermatology. The gel is prepared by mixing the polysaccharide solution and the strongly hydrophilic viscous alcohol before sterilizing the entire mixture by, for example, moist heat.Type: ApplicationFiled: February 14, 2014Publication date: June 12, 2014Applicant: ANTEIS SAInventor: Gilles BOS
-
Publication number: 20130006218Abstract: Assisted injection device including a container for containing a product to be injected, the container including a movable bottom; a needle attached to the end of the container opposite the movable bottom; a piston acting on the movable bottom to expel through the needle a product located in the container and which is to be injected; a rotary motor for moving the piston by means of a drive mechanism, which converts the rotary motion of the rotary motor into a linear motion of the piston, the piston acting on the movable bottom by means of a compressible damping element.Type: ApplicationFiled: September 27, 2010Publication date: January 3, 2013Applicant: ANTEIS SAInventors: Cyrille Vinchon, Vincent Guist'Hau
-
Publication number: 20110230438Abstract: The invention relates to a polysaccharide gel of natural origin for dermatological use that comprises an aqueous solution of the polysaccharide of 0.1 to 5% by weight/volume, for example hyaluronic acid, and a viscous and strongly hydrophilic biocompatible alcohol at 0.5-5% by weight/volume, for example glycerol, and optionally the adjuvants that are commonly used in dermatology. The gel is prepared by mixing the polysaccharide solution and the strongly hydrophilic viscous alcohol before sterilizing the entire mixture by, for example, moist heat.Type: ApplicationFiled: January 5, 2007Publication date: September 22, 2011Applicant: ANTEIS SAInventor: Gilles Bos
-
Publication number: 20100069938Abstract: Eye diseases such as glaucoma can be treated using a composition containing cross-linked hyaluronic acid or a cross-linked salt of hyaluronic acid such as sodium hyalurate. The composition can be a monophasic gel. The composition can include a cross-linking agent such as 1,4-butanediol diglycidylether. The composition can contains about 2.25% (w/w) of the salt of hyaluronic acid. The composition can have a cross-linking rate of about 0.5 to 50%.Type: ApplicationFiled: September 11, 2009Publication date: March 18, 2010Applicant: ANTEIS SAInventor: GILLES BOS
-
Patent number: D641870Type: GrantFiled: October 6, 2010Date of Patent: July 19, 2011Assignee: Anteis SAInventors: Christophe Chedal Anglay, Cyrille Vinchon
-
Patent number: D650075Type: GrantFiled: October 6, 2010Date of Patent: December 6, 2011Assignee: Anteis SAInventors: Christophe Chedal Anglay, Cyrille Vinchon
-
Patent number: D702835Type: GrantFiled: July 3, 2012Date of Patent: April 15, 2014Assignee: Anteis SAInventor: Cyrille Vinchon